1. Home
  2. HLVX vs MIST Comparison

HLVX vs MIST Comparison

Compare HLVX & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLVX
    SELLHOLDBUYas of 13 hours ago
  • MIST
    SELLHOLDBUYas of 13 hours ago
  • Stock Information
  • Founded
  • HLVX 2020
  • MIST 2003
  • Country
  • HLVX United States
  • MIST Canada
  • Employees
  • HLVX N/A
  • MIST N/A
  • Industry
  • HLVX Biotechnology: Pharmaceutical Preparations
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • HLVX Health Care
  • MIST Health Care
  • Exchange
  • HLVX Nasdaq
  • MIST Nasdaq
  • Market Cap
  • HLVX 87.6M
  • MIST 100.3M
  • IPO Year
  • HLVX 2022
  • MIST N/A
  • Fundamental
  • Price
  • HLVX $1.86
  • MIST $1.80
  • Analyst Decision
  • HLVX Hold
  • MIST Strong Buy
  • Analyst Count
  • HLVX 5
  • MIST 3
  • Target Price
  • HLVX $2.33
  • MIST $13.00
  • AVG Volume (30 Days)
  • HLVX 284.4K
  • MIST 369.8K
  • Earning Date
  • HLVX 11-07-2024
  • MIST 11-12-2024
  • Dividend Yield
  • HLVX N/A
  • MIST N/A
  • EPS Growth
  • HLVX N/A
  • MIST N/A
  • EPS
  • HLVX N/A
  • MIST N/A
  • Revenue
  • HLVX N/A
  • MIST N/A
  • Revenue This Year
  • HLVX N/A
  • MIST N/A
  • Revenue Next Year
  • HLVX N/A
  • MIST N/A
  • P/E Ratio
  • HLVX N/A
  • MIST N/A
  • Revenue Growth
  • HLVX N/A
  • MIST N/A
  • 52 Week Low
  • HLVX $1.55
  • MIST $1.12
  • 52 Week High
  • HLVX $20.22
  • MIST $2.93
  • Technical
  • Relative Strength Index (RSI)
  • HLVX 44.78
  • MIST 50.44
  • Support Level
  • HLVX $1.95
  • MIST $1.68
  • Resistance Level
  • HLVX $1.97
  • MIST $1.86
  • Average True Range (ATR)
  • HLVX 0.07
  • MIST 0.09
  • MACD
  • HLVX -0.02
  • MIST -0.02
  • Stochastic Oscillator
  • HLVX 10.00
  • MIST 34.78

Stock Price Comparison Chart: HLVX vs MIST

HLVX
MIST
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober024681012141618202224HLVX VS MIST

About HLVX HilleVax Inc.

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use